L. Dossena

Detection of the SARS‐CoV‐2 in different biologic specimens from positive patients with COVID‐19, in Northern Italy

F. Giardina, F. Rovida, R. Bruno, 2020, Pediatric Allergy and Immunology.

Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing.

F. Rovida, F. Baldanti, M. Capobianchi, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count

F. Rovida, F. Baldanti, R. Maserati, 2020, International Journal of Infectious Diseases.

Clinically‐based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients

F. Rovida, F. Baldanti, D. Lilleri, 2004, Journal of medical virology.

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients

F. Baldanti, G. Barbarini, P. Sacchi, 2012, Virology Journal.

Analysis of HIV drug‐resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment‐naive and HAART patients

F. Baldanti, G. Gerna, M. Zavattoni, 2001, Journal of medical virology.

SARS-CoV-2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit

Carlo U. Nicola, Gherard Batisti Biffignandi, F. Giardina, 2020, Clinical Microbiology and Infection.

Amino acid insertions at position 35 of HIV-1 protease interfere with virus replication without modifying antiviral drug susceptibility.

F. Baldanti, G. Gerna, S. Paolucci, 2006, Antiviral research.